Inspired by nature, Peñafiel's sculpted leather creations take shape as bags, shoes and voluptuously curved furniture. At 75, ...
During 30 months of follow-up, the researchers found that the weighted cumulative incidences of all-cause mortality and hospitalization were 5218 per 10 5 person-years (PY) and 16,334 per 10 5 PY, ...
4d
HealthDay on MSNPatients Hospitalized With COVID-19 Face Higher Long-Term Risk of Mortality, RehospitalizationPatients previously hospitalized for COVID-19 have an increased risk of subsequent death or hospitalization for various organ disorders up to 30 months after discharge.
People hospitalized for a severe bout of COVID-19 are far from in the clear after they've recovered enough to return home, a ...
Adding cabozantinib to first-line treatment with nivolumab and ipilimumab improved PFS — but not OS — in patients with RCC.
These individuals – with an average age of 65 years, with 53.1% male – were matched with 319,891 people ... an Infectious Diseases specialist, at Université Paris Cité. “These results highlight the ...
Newly achieved precise control over light emitted from incredibly tiny sources, a few nanometers in size, embedded in ...
Immunotherapy advances in triple-negative breast cancer drive personalized treatments with immune checkpoint inhibitors, ...
These individuals – with an average age of 65 years, with 53.1% male – were matched with ... at Université Paris Cité. “These results highlight the need for further research to understand ...
The Phase III SERENA-6 trial is the first global trial to use a circulating tumor DNA-guided approach to detect endocrine ...
COVID hospital patients have an increased risk of death from any cause for at least two and a half years following their ...
Camizestrant with a CDK 4/6 inhibitor had a statistically significant and clinically meaningful improvement in PFS in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results